300942 易瑞生物
按盤價 
7.340 +0.390 (+5.612%)
7.340 +0.390 (+5.612%) | 2024/06 - 中期 人民幣(K¥) | 與去年末期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 106,771 | -26.46% | 145,179 | 195,758 | 21,944 | 3,507 |
| 投資性房地產 | 0 | -- | 0 | 0 | 5,250 | 5,387 |
| 固定資產 | 52,995 | -7.19% | 57,102 | 83,986 | 52,628 | 44,887 |
| 在建工程 | 413,142 | 15.85% | 356,626 | 190,867 | 51,341 | 0 |
| 無形資產 | 40,183 | -2.92% | 41,393 | 42,400 | 42,600 | 44,124 |
| 商譽 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動資產 | 5,590 | -69.57% | 18,370 | 95,026 | 81,113 | 28,852 |
| 618,681 | 0.00% | 618,669 | 608,036 | 254,876 | 126,757 | |
流動資產 | ||||||
| 貨幣資金 | 386,556 | -19.76% | 481,749 | 247,451 | 342,211 | 379,097 |
| 應收賬款 | 77,568 | 1.86% | 76,148 | 83,878 | 97,052 | 62,300 |
| 存貨 | 41,045 | 30.46% | 31,461 | 100,608 | 93,859 | 61,590 |
| 其他流動資產 | 270,305 | 82.25% | 148,312 | 242,482 | 364,522 | 23,143 |
| 775,474 | 5.12% | 737,670 | 674,419 | 897,644 | 526,129 | |
流動負債 | ||||||
| 短期借款 | 0 | -- | 0 | 0 | 0 | 0 |
| 應付票據 | 0 | -- | 0 | 0 | 0 | 0 |
| 應付帳款 | 75,270 | -2.69% | 77,352 | 65,107 | 55,658 | 14,644 |
| 其他流動負債 | 83,264 | 39.76% | 59,575 | 134,676 | 100,968 | 63,475 |
| 158,535 | 15.78% | 136,927 | 199,784 | 156,626 | 78,119 | |
| 流動資產淨值 | 616,940 | 2.70% | 600,743 | 474,636 | 741,018 | 448,010 |
| 資產總額減流動負債 | 1,235,621 | 1.33% | 1,219,412 | 1,082,672 | 995,894 | 574,767 |
非流動負債 | ||||||
| 長期借款 | 112,663 | 12.29% | 100,329 | 56,320 | 0 | 0 |
| 應付債券 | 255,510 | 4.10% | 245,452 | 0 | 0 | 0 |
| 其他非流動負債 | 18,623 | -25.22% | 24,903 | 61,651 | 49,314 | 25,784 |
| 386,796 | 4.35% | 370,684 | 117,971 | 49,314 | 25,784 | |
總權益 | ||||||
| 實收股本 | 400,865 | 0.00% | 400,860 | 400,860 | 400,860 | 360,000 |
| 儲備項目 | 446,618 | -0.34% | 448,134 | 564,031 | 543,903 | 189,054 |
| 股東權益 | 847,483 | -0.18% | 848,994 | 964,891 | 944,763 | 549,054 |
| 非控股權益 | 1,341 | -604.14% | (266) | (190) | 1,817 | (70) |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
